Rockville, MD, United States of America

Manuel S Yepes


Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Alexandria, VA (US) (2006 - 2007)
  • Rockville, MD (US) (2008)
  • Atlanta, GA (US) (2011 - 2020)

Company Filing History:


Years Active: 2006-2020

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations of Manuel S Yepes

Introduction

Manuel S Yepes is a prominent inventor based in Rockville, MD (US). He has made significant contributions to the field of medical science, particularly in the modulation of the blood-neural barrier. With a total of 9 patents to his name, his work has the potential to impact the treatment of various central nervous system conditions.

Latest Patents

His latest patents include methods and compositions for the modulation of the blood-neural barrier (BNB). These innovations aim to enhance drug delivery efficacy across the BNB for the treatment of CNS conditions such as edema. Furthermore, his inventions relate to improved tPA treatment of ischemic cerebrovascular diseases, particularly in conjunction with antagonism of the PDGF signaling pathway. The inventive methods and compositions are particularly suitable for the conjunctive therapy of ischemic stroke using tPA and an anti-PDGF-C antagonist or an anti-PDGFR-α antagonist.

Career Highlights

Throughout his career, Manuel S Yepes has worked with esteemed institutions such as the University of Michigan and the University System of Maryland. His research and innovations have garnered attention and respect within the scientific community.

Collaborations

Some of his notable coworkers include Daniel Lawrence and Dudley Strickland. Their collaborative efforts have contributed to the advancement of research in their respective fields.

Conclusion

Manuel S Yepes continues to be a significant figure in the realm of medical innovations, with his work paving the way for new treatments in neurology. His contributions are vital for the ongoing development of therapies aimed at improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…